PureTech Health PLC 2022 AR2
The report details PureTech Health plc's sustainability and operational performance for the fiscal year 2022. The company made significant progress across its Wholly Owned Pipeline and Founded Entities, advancing 27 therapeutics and therapeutic candidates, including late-stage clinical trials for LYT-100 and clinical validation of its Glyph platform with LYT-300. PureTech generated over $115 million in non-dilutive cash from Founded Entity equity sales. In ESG achievements, the company maintained its 'Low Risk' Sustainalytics rating, ranking in the top 3% of pharmaceutical companies globally, and achieved a 74% reduction in energy consumption at its Boston headquarters compared to the 2030 Challenge baseline.
Company: PureTech Health PLC
Sector: Professional & technical services
Country: United States
Year: 2022
Type: AR2
Pages: 109
Back to company
PureTech Health PLC
Annual Report And Accounts
The report details PureTech Health plc's sustainability and operational performance for the fiscal year 2022. The company made significant progress across its Wholly Owned Pipeline and Founded Entities, advancing 27 therapeutics and therapeutic candidates, including late-stage clinical trials for LYT-100 and clinical validation of its Glyph platform with LYT-300. PureTech generated over $115 million in non-dilutive cash from Founded Entity equity sales. In ESG achievements, the company maintained its 'Low Risk' Sustainalytics rating, ranking in the top 3% of pharmaceutical companies globally, and achieved a 74% reduction in energy consumption at its Boston headquarters compared to the 2030 Challenge baseline.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Total Waste
Women on Board
Women in Management
Employees